ProShare Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$412,945
-20.6%
8,979
-0.8%
0.00%
-50.0%
Q2 2023$519,989
+56.0%
9,048
+1.8%
0.00%
+100.0%
Q1 2023$333,263
+18.7%
8,887
-11.3%
0.00%0.0%
Q4 2022$280,844
+6.4%
10,023
+6.8%
0.00%0.0%
Q3 2022$264,000
-17.2%
9,386
+2.2%
0.00%0.0%
Q2 2022$319,000
-32.6%
9,182
-30.3%
0.00%0.0%
Q1 2022$473,000
+27.2%
13,176
-17.5%
0.00%0.0%
Q4 2021$372,000
+22.8%
15,979
+0.1%
0.00%0.0%
Q3 2021$303,000
-21.5%
15,959
-16.7%
0.00%0.0%
Q2 2021$386,000
+21.0%
19,158
+10.2%
0.00%0.0%
Q1 2021$319,000
-1.5%
17,390
+8.0%
0.00%0.0%
Q4 2020$324,000
+35.0%
16,100
+26.0%
0.00%0.0%
Q3 2020$240,000
-16.4%
12,776
+0.1%
0.00%
-50.0%
Q2 2020$287,000
-6.8%
12,769
-20.0%
0.00%
+100.0%
Q4 2019$308,000
-12.5%
15,956
-10.1%
0.00%
-50.0%
Q3 2019$352,000
-9.7%
17,741
-4.0%
0.00%0.0%
Q2 2019$390,000
-6.7%
18,474
-9.8%
0.00%
-33.3%
Q1 2019$418,000
+3.2%
20,479
+0.7%
0.00%0.0%
Q4 2018$405,000
-12.5%
20,343
-15.6%
0.00%0.0%
Q3 2018$463,000
+19.3%
24,089
-5.3%
0.00%0.0%
Q2 2018$388,000
-23.3%
25,432
-5.8%
0.00%0.0%
Q1 2018$506,000
-15.8%
26,993
-13.6%
0.00%
-25.0%
Q4 2017$601,000
+15.1%
31,232
+6.9%
0.00%
-20.0%
Q3 2017$522,000
+7.4%
29,207
+7.3%
0.01%0.0%
Q2 2017$486,000
+13.6%
27,215
-7.7%
0.01%
+25.0%
Q1 2017$428,000
-37.1%
29,498
-20.1%
0.00%
-50.0%
Q4 2016$680,000
+9.7%
36,921
+13.1%
0.01%
-11.1%
Q3 2016$620,000
+2.0%
32,659
-13.5%
0.01%
+12.5%
Q2 2016$608,000
+36.0%
37,737
+1.4%
0.01%
+33.3%
Q1 2016$447,000
-23.1%
37,213
-8.9%
0.01%
-14.3%
Q4 2015$581,000
+32.0%
40,827
+8.5%
0.01%
+16.7%
Q3 2015$440,000
-37.1%
37,612
-5.4%
0.01%
-40.0%
Q2 2015$699,000
+23.7%
39,745
+5.3%
0.01%
+42.9%
Q1 2015$565,000
+54.4%
37,758
+19.7%
0.01%
+75.0%
Q4 2014$366,00031,5480.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders